|国家预印本平台
首页|黄芪甲苷和三七的三种有效成分配伍对小鼠脑缺血再灌注后氧化应激和Nrf2/HO-1途径的影响

黄芪甲苷和三七的三种有效成分配伍对小鼠脑缺血再灌注后氧化应激和Nrf2/HO-1途径的影响

Effects of the combinations between Astragaloside Ⅳ and three active components in notoginseng on oxidative stress and Nrf2/HO-1 pathway after cerebral ischemic -reperfusion in mice

中文摘要英文摘要

目的 研究黄芪的主要有效成分黄芪甲苷分别与三七的有效成分人参皂苷Rg1、人参皂苷Rb1、三七皂苷R1配伍对小鼠脑缺血再灌注后氧化应激和核转录因子E2 相关因子2(nuclear factor-erythroid 2 related factor 2, Nrf2)/血红素加氧酶(heme oxygenase, HO)-1途径的影响。方法 C57BL/6小鼠随机分组,连续给药3天,末次给药1小时后,结扎双侧颈总动脉造成脑缺血20 min,再灌注24 h。测定脑组织丙二醛(malonyldialdehyde, MDA)、一氧化氮(nitric oxide, NO)、超氧化物歧化酶(superoxide dismutase, SOD)、谷胱甘肽(glutathione, GSH),HO-1mRNA表达,脑组织胞核、胞浆Nrf2和全细胞HO-1蛋白表达。结果 1. 脑缺血再灌注后,脑组织MDA、NO含量显著升高,SOD活性和GSH含量显著降低。黄芪甲苷可降低脑组织MDA、NO含量,人参皂苷Rg1能降低脑组织NO含量。黄芪甲苷+人参皂苷Rg1、黄芪甲苷+人参皂苷Rb1和黄芪甲苷+三七皂苷R1均能显著降低脑组织MDA和NO含量,且黄芪甲苷与人参皂苷Rb1、三七皂苷R1配伍的效应大于人参皂苷Rb1单用和三七皂苷R1单用。2. 脑缺血再灌注后,脑组织胞核和胞浆中Nrf2蛋白含量及核转位率升高,同时HO-1mRNA和蛋白表达增强。各给药组能不同程度地降低胞浆Nrf2蛋白含量,升高胞核Nrf2含量,使Nrf2核转位率升高,且黄芪甲苷+人参皂苷Rg1、黄芪甲苷+人参皂苷Rb1、黄芪甲苷+三七皂苷R1的作用强于各有效成分单用。黄芪甲苷、人参皂苷Rg1、黄芪甲苷+人参皂苷Rg1、黄芪甲苷+人参皂苷Rb1、黄芪甲苷+三七皂苷R1可使脑组织HO-1mRNA和蛋白表达显著增加,黄芪甲苷+人参皂苷Rg1、黄芪甲苷+人参皂苷Rb1、黄芪甲苷+三七皂苷R1脑组织HO-1mRNA和蛋白的增加显著高于各有效成分单用。且黄芪甲苷+人参皂苷Rg1升高胞核Nrf2蛋白、提高Nrf2核转位率的作用强于黄芪甲苷+人参皂苷Rb1,增加HO-1基因和蛋白表达的作用强于黄芪甲苷+人参皂苷Rb1和黄芪甲苷+三七皂苷R1。结论 黄芪甲苷分别与三七的三种有效成分配伍可增强其抗脑缺血再灌注后氧化应激损伤的作用,其作用机制可能与激活Nrf2/HO-1信号途径,促进Nrf2合成和核转位,从而促进下游抗氧化基因HO-1等的表达有关,黄芪甲苷与人参皂苷Rg1配伍的效应更为显著。

im To investigate the effects of the combinations between Astragaloside Ⅳ (the effective component of Astragalus) and Ginsenoside Rg1, Ginsenoside Rb1, Notoginsenoside R1 (the effective components of Panax notoginseng) on oxidative stress and nuclear factor-erythroid 2 related factor 2 (Nrf2)/heme oxygenase (HO)-1 pathway after cerebral ischemic-reperfusion in mice. Methods C57BL/6 mice were randomly grouped, treated for 3 days, at 1 h after the last administration, cerebral ischemia-reperfusion injury was established by bilateral common carotid artery ligation for 20 min followed by reperfusion for 24 h. To detect malondialdehyde (MDA)、nitric oxide (NO)、superoxide dismutase (SOD)、glutathione (GSH), HO-1mRNA expression in tissues and the expressions of Nrf2 in cytoplasm and nucleus、HO-1 in whole cell. Results 1. After cerebral ischemic reperfusion for 24 h, the contents of MDA、NO significantly were increased, SOD activity and GSH level were decreased. Astragaloside Ⅳ significantly inhibited the increase of MDA, NO, Ginsenoside Rg1 obviously reduced NO content. Astragaloside Ⅳ+Ginsenoside Rg1, Astragaloside Ⅳ+Ginsenoside Rb1 and Astragaloside Ⅳ+Notoginsenoside R1 all reduced obviously the contents of MDA and NO, and the effects in Astragaloside Ⅳ+Ginsenoside Rb1 and Astragaloside Ⅳ+Notoginsenoside R1 were better than those in Ginsenoside Rb1, Notoginsenoside R1 alone. 2. After cerebral ischemic reperfusion for 24 h, Nrf2 protein content was increased in cytoplasm and nucleus, nuclear translocation rate was raised, at the same time, HO-1mRNA and HO-1 protein expression in brain tissues were significantly up-regulated. In different degree, Nrf2 protein content was significantly decreased in cytoplasm and significantly increased in nucleus, nuclear translocation rate was raised in treatment groups, and the effects in Astragaloside Ⅳ+Ginsenoside Rg1, Astragaloside Ⅳ+Ginsenoside Rb1 and Astragaloside Ⅳ+Notoginsenoside R1 were better than those in the active components alone. Astragaloside Ⅳ, Ginsenoside Rg1, Astragaloside Ⅳ+Ginsenoside Rg1, Astragaloside Ⅳ+Ginsenoside Rb1 and Astragaloside Ⅳ+Notoginsenoside R1 could obviously increase HO-1 mRNA and HO-1 protein, and the effects in Astragaloside Ⅳ+Ginsenoside Rg1, Astragaloside Ⅳ+Ginsenoside Rb1 and Astragaloside Ⅳ+Notoginsenoside R1 were better than those in the active components alone. Furthermore, the elevatory effects of Nrf2 in nucleus, nuclear translocation rate in Astragaloside Ⅳ+Ginsenoside Rg1 were stronger than those in Astragaloside Ⅳ+Ginsenoside Rb1, the elevatory effects of HO-1 mRNA and HO-1 protein were stronger than those in Astragaloside Ⅳ+Ginsenoside Rb1 and Astragaloside Ⅳ+Notoginsenoside R1. Conclusion Astragaloside Ⅳ respectively combined with three active components of Panax notoginseng strengthened the antagonism effects on oxidative stress injury after cerebral ischemic-reperfusion, the mechanism underlying might be associated with activating Nrf2/HO-1 signal transduction pathway, promoting the synthesis and nuclear translocation of Nrf2, then advancing the expression of antioxidant gene in the downstream such as HO-1, which were more obvious in Astragaloside Ⅳ+Ginsenoside Rg1.

黄小平、曾嵘、王蓓、邱咏园、邓常清、唐映红

基础医学药学中医学

脑缺血再灌注损伤中药有效成分配伍黄芪甲苷人参皂苷Rg1人参皂苷Rb1三七皂苷R1氧化应激核转录因子E2 相关因子2血红素加氧酶-1

cerebral ischemia-reperfusion injuryactive component of TCMcombinationAstragaloside ⅣGinsenoside Rg1Ginsenoside Rb1Notoginsenoside R1oxidative stressnuclear factor erythroid-2 related factor 2hemeoxygenase -1

黄小平,曾嵘,王蓓,邱咏园,邓常清,唐映红.黄芪甲苷和三七的三种有效成分配伍对小鼠脑缺血再灌注后氧化应激和Nrf2/HO-1途径的影响[EB/OL].(2013-07-19)[2025-08-02].http://www.paper.edu.cn/releasepaper/content/201307-290.点此复制

评论